BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
32.16
+1.54 (5.02%)
Oct 14, 2025, 3:13 PM EDT
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of $2.84 billion as of October 15, 2025. Its market cap has increased by 99.12% in one year.
Market Cap
2.84B
Enterprise Value
2.64B
Revenue
195.55M
Ranking
n/a
PE Ratio
25.33
Stock Price
$32.16
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 315.33M to 2.84B, an increase of 801.21%. That is a compound annual growth rate of 31.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 2.78B | 74.39% |
| Dec 30, 2024 | 1.60B | -31.92% |
| Dec 29, 2023 | 2.35B | 1.97% |
| Dec 30, 2022 | 2.30B | 98.17% |
| Dec 30, 2021 | 1.16B | 13.19% |
| Dec 30, 2020 | 1.03B | 14.35% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |